These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16497877)

  • 1. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
    Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
    Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress.
    Kokkinakis DM; Liu X; Chada S; Ahmed MM; Shareef MM; Singha UK; Yang S; Luo J
    Cancer Res; 2004 Oct; 64(20):7513-25. PubMed ID: 15492278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
    Khong T; Sharkey J; Spencer A
    Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC
    Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
    Kim IY; Kim BC; Seong DH; Lee DK; Seo JM; Hong YJ; Kim HT; Morton RA; Kim SJ
    Cancer Res; 2002 Sep; 62(18):5365-9. PubMed ID: 12235008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
    Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
    Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
    Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ
    Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
    Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
    He H; Chen L; Zhai M; Chen JZ
    Phytother Res; 2009 Jun; 23(6):868-73. PubMed ID: 19107739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.
    Kim MO; Moon DO; Heo MS; Lee JD; Jung JH; Kim SK; Choi YH; Kim GY
    Cancer Lett; 2008 Nov; 271(1):25-33. PubMed ID: 18602210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides.
    Ma G; Khan SI; Benavides G; Schühly W; Fischer NH; Khan IA; Pasco DS
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):35-43. PubMed ID: 17149609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.